A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions
Hernia, VentralIncisional Hernia
Interventions
DEVICE

Phasix™ ST

Phasix™ ST is a fully resorbable mesh with a hydrogel coating that is also resorbable.

Trial Locations (16)

17033

Hershey Penn State Medical Center, Hershey

24013

Carilion Clinic, Roanoke

28401

New Hanover Regional Medical Center, Wilmington

30322

Emory University, Atlanta

31404

Memorial Health University Medical Center, Savannah

34747

Florida Hospital, Celebration

40324

Georgetown Community Hospital, Georgetown

40536

University of Kentucky Medical Center, Lexington

53792

University of Wisconsin, Madison

63110

Washington University, St Louis

67214

Via-Christi Hospital, Wichita

68114

Methodist Hospital, Omaha

70808

Our Lady of the Lake Regional Medical Center, Baton Rouge

97210

Legacy Emanuel Hospital, Portland

98004

Overlake Hospital, Bellevue

06510

Yale-New Haven Medical Center, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02712398 - A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair | Biotech Hunter | Biotech Hunter